Universal Music Group Files for Public Offering
The Netherlands-based music conglomerate said Monday it had filed a confidential registration statement with the Securities and Exchange Commission proposing the offering.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Why Oklo Stock Is Soaring Higher Today
Key Points Oklo stock is rising today despite a lack of news from the company. BWX Technologies reported strong financial results yesterday, which Oklo investors are seeing as a positive sign for the nuclear energy industry. An investment in Oklo requires a high threshold for risk, so investors shoulda act accordingly. 10 stocks we like better than Oklo › Rebuffing the general bearing sentiment that is driving the S&P 500 (SNPINDEX: ^GSPC) and Dow Jones Industrial Average (DJINDICES: ^DJI) lower today, investors are powered up about nuclear energy stock Oklo (NYSE: OKLO). Although the company hasn't reported any developments to substantiate the stock's rise, there is industry news that investors are interpreting as positive for the small modular reactor (SMR) developer. As of 12:41 a.m. ET, shares of Oklo have risen 8.7%. BWX Technologies just proved that the state of the nuclear energy industry remains strong It's not just speculation that the nuclear energy will soon grow that's driving investor interest into SMR stocks like Oklo. BWX Technologies (NYSE: BWXT) is seeing tangible benefits in its financials. Providing manufacturing and engineering services for the nuclear energy industry, BWXT reported second-quarter 2025 financial results yesterday. Oklo investors are likely giving weight to commentary from Rex Geveden, BWX Technologies president and CEO, who recognized that "demand for nuclear solutions in the global security, clean energy, and medical markets continues to accelerate." Is now the time to buy Oklo stock? The financial results that BWX Technologies reported are certainly encouraging; however, it hardly seems sufficient for investors to predicate an Oklo investment on right now. Nonetheless, Oklo stock is certainly a worthy consideration for those interested in gaining exposure to SMR technology and the growth of the nuclear energy industry. Buying growth stocks such as Oklo -- stocks that aren't generating revenue -- require extremely high tolerances for risk, so investors should act accordingly. Of course, buying a nuclear energy ETF provides another option that helps to gain industry exposure while limiting risk. Should you buy stock in Oklo right now? Before you buy stock in Oklo, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Oklo wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Scott Levine has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends BWX Technologies. The Motley Fool has a disclosure policy. Why Oklo Stock Is Soaring Higher Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
LyondellBasell (LYB) Drops on 6th Day as Earnings Disappoint
We recently published . LyondellBasell Industries N.V. (NYSE:LYB) is one of the companies that stood stronger last week. LyondellBasell dropped its share prices for a sixth straight day on Monday, shedding 4.72 percent to close at $50.9 apiece as investors continued to unload positions following a disappointing earnings performance in the first half of the year. In a statement, LyondellBasell Industries N.V. (NYSE:LYB) said net income in the second quarter of the year declined by 87 percent to $115 million from $924 million in the same period last year, dragged down by asset write-downs, transaction costs, cash improvement plans, and discontinued operations. Sales and operating revenues decreased by 11 percent to $7.66 billion from $8.68 billion. Copyright: art9858 / 123RF Stock Photo Net income for the first half also dwindled by 79 percent to $292 million from $1.397 billion, while sales and operating revenues declined by 9.9 percent to $15.3 billion from $16.98 billion year-on-year. Meanwhile, LyondellBasell Industries N.V. (NYSE:LYB) announced the distribution of $1.37 per share to shareholders as of August 25, payable on September 2, 2025. While we acknowledge the potential of LYB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
21 minutes ago
- Yahoo
Bruker Corp. (BRKR) Sheds 8.6% on Dismal Earnings, Outlook
We recently published . Bruker Corporation (NASDAQ:BRKR) is one of the companies that stood stronger last week. Bruker Corp. fell for a fifth straight day on Monday, dropping 8.62 percent to close at $34.72 apiece after posting a dismal earnings performance in the first half of the year and lowering its growth outlook for full-year 2025. In a statement, Bruker Corporation (NASDAQ:BRKR) said both attributable net income and revenues in the second quarter of the year finished flat at $7.6 million and $800 million, respectively. Looker_Studio/ Meanwhile, attributable net income for the first half declined by 57 percent to $25 million from $58.5 million year-on-year, while revenues were higher by 4 percent to $1.6 billion versus $1.52 billion in the same comparable period. 'Life-science research instruments demand is under pressure at the moment. Our second quarter came in below expectations, as we experienced challenging demand conditions in the US academic market, as well as in biopharma and industrial markets,' said Bruker Corporation (NASDAQ:BRKR) President and CEO Frank Laukien. 'Tariffs and a stiff currency headwind could not yet be compensated for by our mitigating price, supply chain, and cost actions in the second quarter,' he added. For full-year 2025, Bruker Corporation (NASDAQ:BRKR) expects revenues to end at $3.43 billion to $3.5 billion, or a 2-4 percent growth from the $3.37 billion last year. The updated figures, however, were lower than the previous guidance of $3.48 billion to $3.55 billion. While we acknowledge the potential of BRKR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
